This paper is in the following e-collection/theme issue:

RCTs - Protocols/Proposals (eHealth) (387) Coronary Heart Disease (58)

Published on in Vol 9 , No 9 (2020) :September

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/19456, first published .
Telomerase Activation to Reverse Immunosenescence in Elderly Patients With Acute Coronary Syndrome: Protocol for a Randomized Pilot Trial

Telomerase Activation to Reverse Immunosenescence in Elderly Patients With Acute Coronary Syndrome: Protocol for a Randomized Pilot Trial

Telomerase Activation to Reverse Immunosenescence in Elderly Patients With Acute Coronary Syndrome: Protocol for a Randomized Pilot Trial

Authors of this article:

Rebecca Maier 1 Author Orcid Image ;   Bilal Bawamia 2 Author Orcid Image ;   Karim Bennaceur 3 Author Orcid Image ;   Sarah Dunn 1 Author Orcid Image ;   Leanne Marsay 1 Author Orcid Image ;   Roland Amoah 3 Author Orcid Image ;   Adetayo Kasim 4 Author Orcid Image ;   Andrew Filby 5 Author Orcid Image ;   David Austin 2 Author Orcid Image ;   Helen Hancock 1 Author Orcid Image ;   Ioakim Spyridopoulos 3 Author Orcid Image
Article Authors Cited by (1) Tweetations (2) Metrics

Journals

  1. Hoffmann J, Richardson G, Haendeler J, Altschmied J, Andrés V, Spyridopoulos I. Telomerase as a Therapeutic Target in Cardiovascular Disease. Arteriosclerosis, Thrombosis, and Vascular Biology 2021;41(3):1047 View